# VITARA BIOMEDICAL, INC. — Form D/A

VITARA BIOMEDICAL, INC. of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2023-12-06. The offering totals $90.0M, of which $40.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-12-06
- Form: D/A
- Accession: 0001811355-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $90.0M
- Amount sold: $40.0M
- Remaining: $50.0M
- Minimum investment: $59K
- Investors: 9
- Date of first sale: 2022-07-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-454119

## Issuer

- Name: VITARA BIOMEDICAL, INC.
- CIK: 0001811355
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2301 Chestnut Street, PHILADELPHIA, PA, 19103
- Phone: 267-518-6300

## Officers, directors & promoters (15)

| Name | Role | Location |
| --- | --- | --- |
| James McGlone | Director | Philadelphia, PA |
| John Kelly | Executive Officer | New York, NY |
| James McGlone | Executive Officer | Philadelphia, PA |
| Rosaleen Oskanian | Executive Officer | Philadelphia, PA |
| IAN RATCLIFFE | Director | Cambridge, MA |
| Thomas Todorow | Director | Philadelphia, PA |
| Manish Kothari | Director | Philadelphia, PA |
| Bernard Lyons | Director | Philadelphia, PA |
| Bernard Lyons | Executive Officer | Philadelphia, PA |
| Diem Nguyen | Director | Philadelphia, PA |
| Ted Fjallman | Director | Philadelphia, PA |
| Monash Kothari | Director | Philadelphia, PA |
| Arthur Dantchik | Director | PHILADELPHIA, PA |
| Jeffrey Kahn | Executive Officer | PHILADELPHIA, PA |
| Nelson Hill | Director | PHILADELPHIA, PA |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-10-28](https://search.stillhousedata.com/formd/0001811355-24-000001) | D | $50.0M | $10.0M |
| [2023-08-01](https://search.stillhousedata.com/formd/0001811355-23-000001) | D/A | $75.0M | $25.0M |
| [2022-08-02](https://search.stillhousedata.com/formd/0001811355-22-000005) | D/A | $75.0M | $25.0M |
| [2022-07-29](https://search.stillhousedata.com/formd/0001811355-22-000004) | D | $75.0M | $25.0M |
| [2020-05-21](https://search.stillhousedata.com/formd/0001567619-20-010921) | D | $30.0M | $20.0M |

## More

- [CIK 1811355 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1811355&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001811355-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.